We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury (MyDAKI-01)

This study is currently recruiting participants.
Verified December 2016 by Tanya Holt, University of Saskatchewan
Sponsor:
ClinicalTrials.gov Identifier:
NCT01924663
First Posted: August 16, 2013
Last Update Posted: December 6, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Tanya Holt, University of Saskatchewan
August 14, 2013
August 16, 2013
December 6, 2016
September 2013
December 2017   (Final data collection date for primary outcome measure)
  • Myocardial dysfunction, as defined by a low ejection fraction on an Echocardiogram. [ Time Frame: up to 7 days ]
  • Acute Kidney Injury (AKI) as defined by the meeting of the pediatric RIFLE criteria. [ Time Frame: up to 7 days ]
Same as current
Complete list of historical versions of study NCT01924663 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury
Viral Illness in the Pediatric Critical Care Setting: the Incidence, Timing and Severity of Associated Myocardial Dysfunction and Acute Kidney Injury.
The purpose of this study is to be able to better describe the incidence, timing and severity of myocardial dysfunction and acute kidney injury (AKI) following a documented respiratory viral illness (RSV, adenovirus, metapneumovirus, parainfluenza, influenza, etc.) in pediatric patients.

This is a single-centre, prospective and retrospective, descriptive data-collection pilot study.

Prospective Data Collection:

All pediatric patients who are less than 18 years with a confirmed positive respiratory viral swab will be invited to participate.

Retrospective Data Collection:

The retrospective portion of this study will examine a 5 year period prior to the start of enrollment for the prospective study, with the intention to include all pediatric patients who are less than 18 years with a confirmed positive respiratory viral swab and admitted into the local hospital's PICU.

Observational
Observational Model: Case-Only
Not Provided
Not Provided
Probability Sample
Pediatric subjects admitted to the local hospital with a confirmed positive respiratory viral swab.
  • Heart Failure
  • Acute Kidney Injury
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
December 2017
December 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. The parent or legal guardian of the pediatric subject must sign the Consent Form for participants in the prospective portion of the study.
  2. The subject must be no greater than 18 years of age, at the time of consent.
  3. The subject must be admitted to the local hospital.
  4. The subject must have a confirmed positive respiratory viral swab.

Exclusion Criteria:

  1. The parent or legal guardian of the pediatric subject is unavailable or unwilling to sign the Consent Form for participants in the prospective portion of the study.
  2. The subject has had previous kidney injury or myocardial dysfunction prior to positive respiratory viral swab.
  3. The subject has any previous problems (prior to positive respiratory viral swab) with their heart or kidneys that could compromise the results, in the opinion of the Investigator.
Sexes Eligible for Study: All
up to 18 Years   (Child, Adult)
No
Contact: Tanya Holt, M.D. (306) 844-1247 tanya.holt@usask.ca
Canada
 
 
NCT01924663
MyDAKI-01
No
Not Provided
Not Provided
Tanya Holt, University of Saskatchewan
University of Saskatchewan
Not Provided
Principal Investigator: Tanya Holt, M.D. University of Saskatchewan
University of Saskatchewan
December 2016